Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 2Phase EARLY_PHASE1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Genitourinary 1Dermatologic 1

Conditions

Pancreatic Neoplasms 170Neoplasms 66Carcinoma, Non-Small-Cell Lung 49Neoplasm Metastasis 37Unspecified Adult Solid Tumor, Protocol Specific 25Ovarian Neoplasms 21Breast Neoplasms 21Urinary Bladder Neoplasms 20Cholangiocarcinoma 20Lymphoma 19Colorectal Neoplasms 18Lymphoma, Non-Hodgkin 17Lung Neoplasms 17Sarcoma 16Hodgkin Disease 14Fallopian Tube Neoplasms 14Biliary Tract Neoplasms 13Lymphoma, Large B-Cell, Diffuse 12Gallbladder Neoplasms 11Colonic Neoplasms 11Carcinoma, Ovarian Epithelial 11Stomach Neoplasms 10Recurrence 10Solid Tumors 9Bile Duct Neoplasms 8Adenocarcinoma 8Triple Negative Breast Neoplasms 7Small Cell Lung Carcinoma 7Rectal Neoplasms 7Melanoma 7

Interventions

Cyclophosphamide 3pembrolizumab 2Radiotherapy 2Radiation 2Gemcitabine 2Etoposide 2Doxorubicin 2Cryotherapy 2Cryosurgery 2tocilizumab 1selinexor 1robatumumab 1poly ICLC 1olaparib 1montanide ISA 51 1lentiviral minigene vaccine of COVID-19 coronavirus 1flt3 ligand protein 1eltrombopag 1cc-486 1Vincristine 1Trabectedin 1Temozolomide 1Radiotherapy, Intensity-Modulated 1Leukapheresis 1Irinotecan 1Interleukin-2 1Injections 1Imiquimod 1Ifosfamide 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Bone Neoplasms × Gemcitabine × Clear all
NCT03093909 2026-05-20

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

M.D. Anderson Cancer Center

Phase 1 Recruiting
44 enrolled
DermatologicGenitourinarySarcoma

Bone Neoplasms, Melanoma, Osteosarcoma, Urologic Neoplasms

NCT01803152 2024-07-03

Dendritic Cell Vaccine for Children and Adults With Sarcoma

University of Miami

Phase 1 Completed
19 enrolled
Sarcoma

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡